Evidence map›Paper›PMID 29499066›Full record

ArticlePLoS pathogens2018

The interferon-stimulated gene product oligoadenylate synthetase-like protein enhances replication of Kaposi's sarcoma-associated herpesvirus (KSHV) and interacts with the KSHV ORF20 protein.

Kendra A Bussey, Ulrike Lau, Sophie Schumann, Antonio Gallo, Lisa Osbelt, Markus Stempel, Christine Arnold, Josef Wissing, Hans Henrik Gad, Rune Hartmann and 4 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Comparative Review of the Conserved UL24 Protein Family in Herpesviruses.International journal of molecular sciences · 2024
    Review
  3. Article
  4. The Many Faces of Oligoadenylate Synthetases.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2023
    Review
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Spotted Fever GroupMicrobiology spectrum · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. A Pathogen and a Non-pathogen Spotted Fever GroupFrontiers in cellular and infection microbiology · 2019
    Article
  18. Article
  19. A Mutation in theJournal of virology · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 3 countries.

Kendra A BusseyViral Immune Modulation Research Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0002-9357-1456
Ulrike LauViral Immune Modulation Research Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0002-4213-116X
Sophie SchumannSchool of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.ORCID 0000-0002-0227-1360
Antonio GalloHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.ORCID 0000-0002-4045-3237
Lisa OsbeltViral Immune Modulation Research Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.
Markus StempelViral Immune Modulation Research Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0002-9240-3987
Christine ArnoldViral Immune Modulation Research Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0003-3145-4382
Josef WissingCellular Proteomics Research Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0002-0320-5883
Hans Henrik GadCenter for Structural Biology, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.ORCID 0000-0001-8449-1115
Rune HartmannCenter for Structural Biology, Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark.ORCID 0000-0003-1159-066X
Wolfram BruneHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.ORCID 0000-0002-6078-5255
Lothar JänschCellular Proteomics Research Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0002-5655-1181
Adrian WhitehouseSchool of Molecular and Cellular Biology and Astbury Centre for Structural Molecular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United Kingdom.ORCID 0000-0003-3866-7110
Melanie M BrinkmannViral Immune Modulation Research Group, Helmholtz Centre for Infection Research (HZI), Braunschweig, Germany.ORCID 0000-0001-5431-6527
Helmholtz Centre for Infection Research · DEAarhus University · DKLeibniz Institute of Virology (LIV) · DEUniversity of Leeds · GBMedizinische Hochschule Hannover · DE

Funding

Biotechnology and Biological Sciences Research Council BB/M006557/1
6 · The paper itself

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is one of the few oncogenic human viruses known to date. Its large genome encodes more than 85 proteins and includes both unique viral proteins as well as proteins conserved amongst herpesviruses. KSHV ORF20 is a member of the herpesviral core UL24 family, but the function of ORF20 and its role in the viral life cycle is not well understood. ORF20 encodes three largely uncharacterized isoforms, which we found were localized predominantly in the nuclei and nucleoli. Quantitative affinity purification coupled to mass spectrometry (q-AP-MS) identified numerous specific interacting partners of ORF20, including ribosomal proteins and the interferon-stimulated gene product (ISG) oligoadenylate synthetase-like protein (OASL). Both endogenous and transiently transfected OASL co-immunoprecipitated with ORF20, and this interaction was conserved among all ORF20 isoforms and multiple ORF20 homologs of the UL24 family in other herpesviruses. Characterization of OASL interacting partners by q-AP-MS identified a very similar interactome to that of ORF20. Both ORF20 and OASL copurified with 40S and 60S ribosomal subunits, and when they were co-expressed, they associated with polysomes. Although ORF20 did not have a global effect on translation, ORF20 enhanced RIG-I induced expression of endogenous OASL in an IRF3-dependent but IFNAR-independent manner. OASL has been characterized as an ISG with antiviral activity against some viruses, but its role for gammaherpesviruses was unknown. We show that OASL and ORF20 mRNA expression were induced early after reactivation of latently infected HuARLT-rKSHV.219 cells. Intriguingly, we found that OASL enhanced infection of KSHV. During infection with a KSHV ORF20stop mutant, however, OASL-dependent enhancement of infectivity was lost. Our data have characterized the interaction of ORF20 with OASL and suggest ORF20 usurps the function of OASL to benefit KSHV infection.

Indexed as

Virus Replication2',5'-Oligoadenylate SynthetaseAmino Acid SequenceCells, CulturedGene Expression Regulation, ViralHerpesviridae InfectionsHerpesvirus 8, HumanHumansInterferonsOpen Reading FramesRibosomal ProteinsViral Proteins2',5'-Oligoadenylate SynthetaseInterferonsRibosomal ProteinsViral Proteins

Identifiers

PMID29499066
PMCPMC5851652
OpenAlexW2789159124

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.